Varenzin ca1 where to buy

Elanco's Varenzin-CA1 is the first drug for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats.

Varenzin-CA1 - Molidustat Oral Suspension for Cat Anemia Treatment (25mg/ml, 27ml) $54.25 Save $-54.25 Varenzin-CA1 for Cat Anemia Treatment Varenzin-CA1

Elanco Animal Health Inc. received conditional approval from the Food and Drug Administration on Monday for its drug Varenzin-CA1 to treat anemia in cats with chronic kidney disease. The agency said Varenzin-CA1 helps to increase production of erythropoietin in the kidney, which in turn stimulates the bone marrow to produce more red blood cells.

Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to

Elanco s Varenzin-CA1 is the first drug for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats for which the Food and Drug Administration (FDA) has granted conditional approval, the agency announced May 1. Varenzin-CA1 is available only by prescription from a licensed veterinarian.

Varenzin-CA1 (molidustat oral suspension), 25 Varenzin-CA1 (molidustat oral suspension). 25 mg Please order product based on its description.

Varenzin-CA1 is a liquid given by mouth to the cat once daily for up to 28 days. The treatment may be repeated as needed after a minimum seven-day pause. Varenzin-CA1 is available only by prescription from a licensed veterinarian given that professional expertise is required to properly diagnose CKD and nonregenerative anemia in cats.

Varenzin-CA1 (molidustat oral suspension) Dosage And Administration. Shake well before use. The dosage of Varenzin-CA1 is 2.3 mg/lb (5 mg/kg) body weight (bw)

FDA conditionally approved Varenzin-CA1 (molidustat oral suspension) the first drug for the control of nonregenerative anemia associated